CDX2 is an intestine-specific, Drosophila caudal-related homeobox transcription factor that is important for the establishment and maintenance of intestinal epithelial cells (James et al., 1994). Mice ...

A new biomarker, the CDX2 protein, can identify a small subgroup of patients with stage II colorectal cancer (CRC) who are likely to benefit from adjuvant chemotherapy, say researchers. At present, ...

The distribution and expression of MUC2, MUC5AC and CDX2 were examined immunohistochemically. As for the primary antibodies, the following were used: MUC2 (Novocastra, New Castle, UK; close Ccp58, ...

The lack of caudal-type homeobox transcription factor 2 expression identified patients with high-risk stage II colon cancer who benefited from adjuvant chemotherapy, according to research published in ...

Impact of genomic alterations (GAs) on outcomes and their distribution by age groups in metastatic colorectal cancer (mCRC) patients (pts). Using circulating tumor DNA (ctDNA) to predict surgical ...

To the Editor: Dalerba and coworkers (Jan. 21 issue) 1 report that they identified and validated caudal-type homeobox transcription factor 2 (CDX2) as a prognostic biomarker associated with ...

Using a new computer science approach, researchers at University of California, San Diego School of Medicine, Columbia University and Stanford University discovered a distinctive molecular feature — a ...

Researchers from Harvard Medical School, Boston, have found that most individuals with acute myeloid leukemia (AML) inappropriately express a protein known as CDX2 in their leukemic cells. CDX2 ...

Researchers at University of California, San Diego School of Medicine, Columbia University and Stanford University have discovered a distinctive molecular feature that identifies colon cancer patients ...

Researchers demonstrate regenerative capability of placental Cdx2 cells in mouse model of heart attack. Researchers from the Icahn School of Medicine at Mount Sinai (NY, USA) have recently ...